ABSTRACT
INTRODUCTION
Type I diabetes is a devastating disease that occurs most often in children or young adults. This disease is characterized by the profound destruction of the β-cells of the Islets of Langerhans in the pancreas, resulting in the inability to produce insulin. Without insulin, severe disturbance in glucose metabolism results, causing intracellular starvation and a dramatic elevation in blood glucose levels or hyperglycemia
(1) . Hyperglycemia in type 1 diabetes probably results from a long-term negative balance between immunemediated β-cell damage and β cell repair/regeneration. Once macrophages and T-cells have been attracted to the islets and activated, they secrete soluble mediators such as cytokines, oxygen free radicals, and nitric oxide (NO), which probably contribute to β-cell dysfunction and death (2) . Lipid peroxidation is probably the most extensively investigated process induced by free radicals. These compounds are abundant at the membrane level, where most of the reactive radicals, especially reactive oxygen species, are formed. Moreover, lipid peroxidation may result in a chain reaction that autopropagates once started, leading to the formation of many lipid peroxide radicals and amplifying the ROS effect (3) . Extensive lipid peroxidation in biological membranes causes loss of fluidity and increased permeability to H + ions and other ions as well as eventual rupture leading to release of cell and organelle contents. Some end products of lipid peroxidation are cytotoxic,
i.e. Malondialdehyde (MDA). Lipid peroxides and cytotoxic aldehydes can block macrophage action, inhibit protein synthesis, inactivate enzymes, cross link proteins and generate thrombin (4) . Proinflammatory cytokines such as interleukin (IL)-1β, interferon (IFN)-γ, and tumor necrosis factor-α (TNF-α) are critically involved in the pathogenesis of type 1 diabetes. Free radicals, particularly reactive oxygen species (ROS), have been implicated in the cytokine mediated Islet cell injury, mostly on the basis of the protective effect of antioxidants in different models of type 1 diabetes. ROS generation, evidenced by the formation of lipid peroxidation products, is believed to be the ultimate cause of cytokine-mediated death of β-cells in isolated Islets (5) .
Antioxidants protect the body from some of the damaging effects of free radicals. To protect itself from excessive exposure to free radicals, the body can make its own antioxidants by using some of the following nutrients that are found in food or supplements such as N-acetylcysteine (NAC), alpha-lipoic (LA), vitamin E and vitamin C (6) . The aim of this study was to evaluate the potential usefulness of antioxidants [N-acetyl-cysteine (NAC), alpha-lipoic acid (LA), vitamin E and vitamin C] supplementation in the treatment of type 1 diabetes. The severity of diabetes in the different groups will be studied in relation to the level of cytokines released during the oxidative stress.
MATERIALS & METHODS

Experimental animals:
The present study was achieved using 24 male Sprague Dawley albino rats, weighing 150-200g were housed in well ventilated room for 2 weeks before carrying out the experiment and they maintained on commercial rodent diet and water.
Induction of diabetes:
Diabetes 
Experimental design:
Rats were divided into three groups of eight animals as follows: Group 1: Non diabetic normal control rats given distilled water (1 ml / 100 g body weight) for two months. Group 2: Cyclophosphamide-induced diabetic control rats given distilled water (1 ml / 100 g body weight) for two months. Group 3: Cyclophosphamide-induced diabetic rats given mixture of the following antioxidants: NAC solution (500 mg / kg body weight) (8) , LA solution (30 mg / kg body weight) (9) , Vitamin E (100 IU / kg body weight) (9) and Vitamin C (1 g / kg body weight) (9) . The mixture of antioxidants was administered daily by using a stainless-steel stomach tube once a day daily for a period of two months, then, the body weight and fasting blood glucose of the animals were again determined.
Collection of blood and tissue samples:
After two months of treatment with antioxidants, the rats were fasted overnight and sacrificed by cervical decapitation. Blood samples were immediately collected for biochemical analysis. The first sample is whole blood for measuring glutathione level and glutathione peroxidase activity, the second one is serum for measuring nitric oxide level and the third one is plasma for measuring fasting glucose level and lipid peroxide level. The plasma has been separated by centrifugation of blood for 10 minutes at 3000 rpm by using K 2 EDTA (dipotassium salts of ethylenediaminetetraacetic acid) as anticoagulant. 
RESULTS
The experimental diabetogenic effect of cyclophosphamide seen in the present study induced high significantly increase (P<0.001) in fasting plasma glucose, lipid peroxides, and nitric oxide levels, when compared with control group as shown in table (1) and figures (1-3).
After treatment of the diabetic rats with the antioxidants for two months, the results showed a highly significant decrease (p< 0.001) in fasting plasma glucose level, lipid peroxides level, and nitric oxide level, when compared with the diabetic group (table 1 and  figures 1-3) . The glutathione (GSH) level and the glutathione peroxidase (GPX) activity of the diabetic rats showed a highly significant decrease (p< 0.001), when compared with control group (table 1 and figures 4, 5).
After supplementation of diabetic rats with the antioxidants for two months showed a highly significant increase (p< 0.001) in glutathione (GSH) level and glutathione peroxidase (GPX) activity when compared with the diabetic group (table 1 and figures 4, 5). 
DISCUSSION
Hyperglycemia results in the generation of reactive oxygen species (ROS), ultimately leading to increased oxidative stress in a variety of tissues. In the absence of an appropriate compensatory response from the endogenous antioxidant network, the system becomes overwhelmed (redox imbalance), leading to the activation of stress-sensitive intracellular signaling pathways. The existence of common biochemical processes whereby oxidative stress induced by hyperglycemia and FFA causes insulin resistance, β-cell dysfunction, and late diabetic complications (15) . The pathogenesis of type 1 diabetes is characterized by an inflammatory reaction that is caused, at least in part, by inflammatory cytokines produced by infiltrating T-lymphocytes and/or macrophages in and around islets.
Inflammatory cytokines, such as TNF-α produced by these cells, initiate a variety of signal cascades in β-cells that lead to β-cell dysfunction and destruction (16) (23) . Vitamin E is an important antioxidant. It acts as a free radical scavenger to prevent the byproducts of chemical-cell interaction to cause cell damage (24) . It also plays some role in the body's ability to process glucose, so it may eventually prove to be helpful in the prevention and treatment of diabetes (25) . α-tocopherol form of vitamin E is the most important lipid-soluble antioxidant, and that it protects membranes from oxidation by reacting with lipid radicals produced in the lipid peroxidation chain reaction. This removes the free radical intermediates and prevents the propagation reaction from continuing. This reaction produces oxidized α-tocopheroxyl radicals that can be recycled back to the active reduced form through reduction by other antioxidants. This is in line with findings showing that α-tocopherol, efficiently protects glutathione peroxidase from cell death (26) . Vitamin C" or ascorbic acid is a monosaccharide antioxidant found in both animals and plants (27) . It is a reducing agent and can reduce and thereby neutralize reactive oxygen species such as hydrogen peroxide (28) . It can benefit in preventing endothelial dysfunction and altering lipid profiles and coagulation factors to preventing blood vessel changes that can lead to strokes and other vascular catastrophes (29) . In conclusions, our observations indicate that antioxidant (NAC, LA, vitamin E and vitamin C) treatment can exert beneficial effects in diabetes, with preservation of in vivo β-cell function. This finding suggests a potential usefulness of antioxidants for treating diabetes and provides further support for the implication of oxidative stress in β-cell dysfunction in diabetes by providing protection against glucose toxicity. 
